These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10232683

  • 1. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
    Finch JL, Brown AJ, Slatopolsky E.
    J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
    [Abstract] [Full Text] [Related]

  • 2. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E.
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [Abstract] [Full Text] [Related]

  • 3. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 4. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
    Slatopolsky E, Finch J, Ritter C, Denda M, Morrissey J, Brown A, DeLuca H.
    Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144
    [Abstract] [Full Text] [Related]

  • 5. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R, Arabian A, Yu VW, Akhouayri O, Knutson JC, Strugnell SA.
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [Abstract] [Full Text] [Related]

  • 6. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
    Erben RG, Bante U, Birner H, Stangassinger M.
    Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF.
    J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
    [Abstract] [Full Text] [Related]

  • 9. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.
    DeLuca HF, Sicinski RR, Tanaka Y, Stern PH, Smith CM.
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E402-6. PubMed ID: 2833108
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.
    Coyne DW, Grieff M, Ahya SN, Giles K, Norwood K, Slatopolsky E.
    Am J Kidney Dis; 2002 Dec; 40(6):1283-8. PubMed ID: 12460048
    [Abstract] [Full Text] [Related]

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Dec; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
    Knutson JC, LeVan LW, Valliere CR, Bishop CW.
    Biochem Pharmacol; 1997 Mar 21; 53(6):829-37. PubMed ID: 9113104
    [Abstract] [Full Text] [Related]

  • 13. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E.
    J Bone Miner Res; 1992 Jul 21; 7(7):835-9. PubMed ID: 1642151
    [Abstract] [Full Text] [Related]

  • 14. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 21; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.
    Slatopolsky E, Cozzolino M, Finch JL.
    Kidney Int; 2002 Oct 21; 62(4):1277-84. PubMed ID: 12234297
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism.
    Finch JL, Brown AJ, Kubodera N, Nishii Y, Slatopolsky E.
    Kidney Int; 1993 Mar 21; 43(3):561-6. PubMed ID: 8455354
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J.
    Kidney Int; 2003 Jun 21; 63(6):2020-7. PubMed ID: 12753289
    [Abstract] [Full Text] [Related]

  • 18. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
    Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS.
    Kidney Int; 2001 Dec 21; 60(6):2109-17. PubMed ID: 11737585
    [Abstract] [Full Text] [Related]

  • 19. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ, Ritter CS, Knutson JC, Strugnell SA.
    Nephrol Dial Transplant; 2006 Mar 21; 21(3):644-50. PubMed ID: 16221703
    [Abstract] [Full Text] [Related]

  • 20. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E.
    J Clin Invest; 1989 Sep 21; 84(3):728-32. PubMed ID: 2760211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.